Viewing Study NCT06874933


Ignite Creation Date: 2025-12-25 @ 3:05 AM
Ignite Modification Date: 2026-01-01 @ 3:51 AM
Study NCT ID: NCT06874933
Status: RECRUITING
Last Update Posted: 2025-08-12
First Post: 2025-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03)
Sponsor: First Affiliated Hospital of Zhejiang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module